A detailed history of Schonfeld Strategic Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 457,801 shares of BMY stock, worth $26.5 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
457,801
Previous 1,052,913 56.52%
Holding current value
$26.5 Million
Previous $43.7 Million 45.82%
% of portfolio
0.17%
Previous 0.3%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $23.6 Million - $30.8 Million
-595,112 Reduced 56.52%
457,801 $23.7 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $27.9 Million - $36.7 Million
692,621 Added 192.24%
1,052,913 $43.7 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $6.4 Million - $7.26 Million
133,435 Added 58.82%
360,292 $19.5 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $6.42 Million - $7.67 Million
132,506 Added 140.44%
226,857 $11.6 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $4.97 Million - $5.55 Million
85,812 Added 1004.94%
94,351 $5.48 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $7.75 Million - $8.61 Million
-121,663 Reduced 93.44%
8,539 $546,000
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $12.9 Million - $14.6 Million
-196,475 Reduced 60.14%
130,202 $9.02 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $15 Million - $17.7 Million
218,577 Added 202.2%
326,677 $23.5 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $200 - $118,256
-1,539 Reduced 1.4%
108,100 $7.68 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $144,876 - $159,560
-1,995 Reduced 1.79%
109,639 $8.44 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $6.33 Million - $7.6 Million
103,034 Added 1198.07%
111,634 $8.15 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $6.07 Million - $7.08 Million
-113,239 Reduced 92.94%
8,600 $537,000
Q3 2021

Nov 16, 2021

BUY
$59.17 - $69.31 $2.51 Million - $2.94 Million
42,401 Added 53.38%
121,839 $7.21 Million
Q2 2021

Nov 16, 2021

SELL
$61.91 - $67.42 $2.48 Million - $2.7 Million
-40,000 Reduced 33.49%
79,438 $5.31 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $3.13 Million - $3.4 Million
-50,502 Reduced 29.72%
119,438 $7.98 Million
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $8.92 Million - $10 Million
150,240 Added 762.64%
169,940 $10.7 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $3.84 Million - $4.35 Million
-66,475 Reduced 77.14%
19,700 $1.22 Million
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $61,048 - $67,649
1,063 Added 1.25%
86,175 $5,000
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $3.81 Million - $4.45 Million
69,481 Added 444.51%
85,112 $5 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $1.93 Million - $2.8 Million
-41,569 Reduced 72.67%
15,631 $871,000
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $2.81 Million - $3.67 Million
57,200 New
57,200 $3.67 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $444,808 - $527,384
-10,400 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $11.2 Million - $12.4 Million
-251,600 Reduced 96.03%
10,400 $472,000
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $11.8 Million - $14.1 Million
262,000 New
262,000 $12.5 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $1.38 Million - $1.8 Million
-28,400 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $780,883 - $880,775
14,149 Added 99.28%
28,400 $1.76 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $720,103 - $897,527
14,251 New
14,251 $789,000
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $1.33 Million - $1.54 Million
-22,256 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $868,530 - $946,921
14,490 Added 186.58%
22,256 $1.36 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $428,916 - $495,004
7,766
7,766 $495,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.